Release Date: 30/04/13 18:13 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 256.96KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%